Introduction: Although osteosarcoma represents the most common primary malignant bone tumor in children, they comprise only 0.2% of all cancers. Osteosarcoma frequently involves long bones; however, 8% of osteosarcomas involve the skull or mandible. Osteosarcoma is generally categorized based on location within the bone (central, surface, or extraskeletal) and histological grade (high-grade or low-grade). Osteoblastic osteosarcoma is a central, high-grade subtype and may be difficult to diagnose; it may present similarly to osteoblastoma, another rare, but benign, type of osteoblastic bone tumor. In this report, we present a rare case of osteoblastic osteosarcoma involving the temporal-occipital skull.
Study Design: Case report and systematic review.
Setting: Tertiary referral center.
Results: A 21-year-old male presented for assessment of a mass appearing over his left mastoid region, first noticed within the previous 12 months. He experienced growth of the lesion and pain that increased when pressure was applied to the mass. Results from fine needle aspiration and CT-guided core biopsy were positive for osteosarcoma, osteoblastic-type. Magnetic resonance imaging of the brain and skull base revealed the mass to be 2.8 cm in maximal diameter. Given a somewhat favorable location, the tumor could be completely excised en bloc with negative margins, and the patient subsequently received adjuvant chemotherapy. The patient is doing well at last follow-up 10 months after surgery, with no evidence of recurrence to date.
Conclusion: The temporal bone is an uncommon location for a primary osteosarcoma, and there are numerous conditions that could present in a similar manner. This case highlights this rare occurrence of osteoblastic osteosarcoma of the temporal bone without previous exposure to radiation. There are a limited number of similar cases in the literature, and our report serves to bring awareness to this potential diagnosis and considerations related to treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MAO.0000000000004481 | DOI Listing |
Front Immunol
March 2025
Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Background: Osteosarcoma, an aggressive bone malignancy predominantly affecting children and adolescents, presents significant therapeutic challenges with a 5-year survival rate below 30% in metastatic cases. T-cell exhaustion, characterized by the overexpression of immune checkpoint molecules, contributes to osteosarcoma progression and immune evasion. Although targeting these inhibitory pathways has shown potential in restoring T-cell activity, the molecular regulators of T-cell depletion in osteosarcoma are poorly understood.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
January 2025
Dentistry Unit, AOU "Maggiore della Carita", 28100 Novara, Italy.
Ewing's sarcoma (ES) is a small round cell tumor that mainly involves the skeleton, with an incidence of 2.93 per million. It is responsible for 4-10% of all bone tumors, with long bones and pelvis being the most frequently observed locations, whereas it affects the skull in only about 1-4% of cases.
View Article and Find Full Text PDFFront Vet Sci
February 2025
Experimental Animal Disease Model Research Laboratory, School of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.
During routine health examinations, an abnormal growth was detected in the oral cavity of a male giant panda. A malignant tumor, osteosarcoma, was diagnosed through CT (computed tomography) scans and pathological examination of biopsy samples. After two attempts at "tumor reduction surgery" with no improvement, the condition stabilized following particle implantation and arterial infusion interventional therapy.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
February 2025
Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh India.
Osteosarcoma, although the most common malignant bone tumor in long bones, represents only 5-8% of head and neck tumors, making it uncommon for clinicians. Conventional biopsy techniques can complicate diagnosis due to varying tissue representation in surrounding areas. This article discusses a case involving a 19-year-old female who presented with facial swelling and a rapidly growing intraoral mass.
View Article and Find Full Text PDFJ Neurosurg Case Lessons
March 2025
Department of Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Background: Osteosarcoma (OS) is a rare malignant bone tumor, with 4% of cases affecting the spine. OS in the spine is as common as Ewing sarcoma in the spine, comprising 10%-15% of cases, and occurs more frequently in older adults in comparison with OS of the limb. The standard treatment for limb OS involves neoadjuvant chemotherapy followed by en bloc resection with tumor-free margins.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!